Abstracts Archive - Page 2205 of 2425 - ACR Meeting Abstracts

Abstract Number: 678 • 2013 ACR/ARHP Annual Meeting
Quantifying Change In Pulmonary Function As a Prognostic Marker In Systemic Sclerosis-Related Interstitial Lung Disease
Owen Moore^1,2, Susanna Proudman³, Nicole Goh⁴, Tamera Corte⁵, Hannah Rouse⁶, Oliver Hennessy⁶, Vivek Thakkar⁷, Joanne Sahhar⁸, Janet E. Roddy⁹, Peter Youssef¹⁰, Eli Gabbay¹¹, Peter Nash¹², Jane Zochling¹³, Wendy Stevens¹⁴ and Mandana Nikpour¹⁵, ¹Rheumatology, St. Vincent’s Hospital, Melbourne, Australia, ²Rheumatology, Derriford Hospital, Plymouth, United Kingdom, ³Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia, ⁴Department of Respiratory Medicine, Alfred Hospital, Melbourne, Australia, ⁵Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia, ⁶Department of Radiology, St. Vincent’s Hospital, Melbourne, Australia, ⁷St Vincent's Hospital, Melbourne, Australia, ⁸Rheumatology Unit, Monash Medical Centre, Clayton, Australia, ⁹Royal Perth Hospital, Perth, Australia, ¹⁰Department of Rheumatology, Royal Prince Alfred Hospital, Sydney, Australia, ¹¹Advanced Lung Disease Unit, Royal Perth Hospital, Perth, Australia, ¹²Rheumatology Research Unit, Nambour Hospital, Sunshine Coast, Australia, ¹³Menzies Research Institute Tasmania, Hobart, Australia, ¹⁴Rheumatology, St Vincent's Hospital, Melbourne, Australia, ¹⁵Department of Medicine (St Vincent's Hospital), University of Melbourne, Fitzroy, Australia
Background/Purpose: Interstitial lung disease (ILD) is a leading cause of mortality in systemic sclerosis (SSc) but it is not severe or progressive in all patients.…
Abstract Number: 679 • 2013 ACR/ARHP Annual Meeting
Validation Of a Novel Radiographic Scoring System For Calcinosis Affecting The Hands Of Patients With Systemic Sclerosis
Lorinda Chung¹, Antonia Maria Valenzuela Vergara², David Fiorentino³, Kate Stevens², Shufeng Li⁴, Jonathan Harris⁵, Charles E. Hutchinson⁶, Shervin Assassi⁷, Lorenzo Beretta⁸, Santhanam Lakshminarayanan⁹, Tatiana Rodriguez Reyna¹⁰, Christopher P. Denton¹¹, Rebecca G. Taillefer¹², Solene Tatibouet¹³, Ariane Herrick¹⁴ and Murray Baron¹⁵, ¹Rheumatology, Stanford Univ Medical Center, Palo Alto, CA, ²Stanford University School of Medicine, Stanford, CA, ³Dermatology, Stanford University School of Medicine, Redwood City, CA, ⁴Dermatology, Stanford University School of Medicine, Palo Alto, CA, ⁵Salford Royal Hospital, Manchester, United Kingdom, ⁶Warwick Medical School, University of Warwick, Coventry, United Kingdom, ⁷Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, ⁸Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, ⁹Dept of Med/Div Rheum Diseases, University of Connecticut School of Medicine, Farmington, CT, ¹⁰Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico, ¹¹Centre for Rheumatology, Royal Free and University College Medical School, London, United Kingdom, ¹²University of Montreal, Montreal, QC, Canada, ¹³Jewish General Hospital, McGill University, Montreal, QC, Canada, ¹⁴Musculoskeletal Research Group, University of Manchester, Salford, United Kingdom, ¹⁵Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada
Background/Purpose: Calcinosis affects approximately 25% of patients with systemic sclerosis (SSc) and is associated with substantial morbidity. There are currently no validated outcome measures…
Abstract Number: 680 • 2013 ACR/ARHP Annual Meeting
Diastolic Dysfunction Amongst Autoantibody Subgroups Of Patients With Diffuse Scleroderma
Cory Perugino¹, John Stephens², Colin O'Rourke³ and Soumya Chatterjee⁴, ¹Internal Medicine, Cleveland Clinic, Cleveland, OH, ²Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, ³Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, ⁴Rheumatic and Immunologic Ds, Cleveland Clinic, Cleveland, OH
Background/Purpose: Scleroderma or systemic sclerosis (SSc) is an autoimmune disease characterized by microangiopathy, tissue hypoxia, and fibrosis. At least seven different autoantibodies have been identified…
Abstract Number: 682 • 2013 ACR/ARHP Annual Meeting
Effects Of Extracoporeal Shock Wave Therapy To The Digital Ulcers Of Scleroderma:a Pilot Study
Shinichiro Saito¹, Yukiko Kamogawa², Kyohei Nakamura³, Ryu Watanabe³, Tsuyoshi Shirai², Yoko Fujita⁴, Hiroshi Fujii³, Yuko Shirota⁵, Tomonori Ishii³, Hideo Harigae³, Katsuko Kikuchi⁶ and Yasushi Kawaguchi⁷, ¹Department of hematology and rheumatology, Tohoku University, Sendai, Japan, ²Tohoku University, Sendai, Japan, ³Department of Hematology and Rheumatology, Tohoku University, Sendai, Japan, ⁴Department of Hematolgy and rheumatolgy, Tohoku University, Sendai, Japan, ⁵Department of Hematology and Rheumatolgy, Tohoku University, Sendai, Japan, ⁶Department of Dermatology, Tohoku University, Sendai, Japan, ⁷Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan
Background/Purpose: Vasculopathy, immunological abnormalities and excessive tissue fibrosis are key elements in the pathogenesis of Scleroderma (SSc). In winter, patients often display Raynaud syndrome, which…
Abstract Number: 683 • 2013 ACR/ARHP Annual Meeting
HRCT Predictors Of Decline In FVC% predicted—Implications For Cohort Enrichment For Scleroderma Lung Disease (SLD) Trials
Dinesh Khanna¹, Chi-hong Tseng², Robert D. Suh³, Fereidoun Abtin⁴, Athol U. Wells⁵, Donald Tashkin⁶ and Jonathan Goldin⁷, ¹University of Michigan, Ann Arbor, MI, ²Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, ³UCLA Department of Radiological Sciences, Ronald Reagan UCLA Medical Center, Los Angeles, CA, ⁴Radiology, University of California Los Angeles Medical Center, Santa Monica, CA, ⁵Royal Brompton and Harefield NHS Foundation Trust, Department of Radiology, London, United Kingdom, ⁶Medicine, University of California at Los Angeles, Los Angeles, CA, ⁷Radiology, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA
Background/Purpose: Moderate-to-severe HRCT-defined lung involvement (total lung involvement or fibrosis) is a predictor of decline in FVC% predicted and mortality in SLD. Various staging systems…
Abstract Number: 684 • 2013 ACR/ARHP Annual Meeting
Clinical Characteristics Of Scleroderma Patients With Calcinosis In a Single-Center Cohort
Danielle Velez¹ and Vivien M. Hsu², ¹RWJMS, South Plainfield, NJ, ²Rheumatology, RWJ Med Schl Scleroderma Prog, New Brunswick, NJ
Clinical characteristics of scleroderma patients with calcinosis in a single-center cohort Background/Purpose: Calcinosis is soft tissue deposition of calcium hydroxyapatite crystals in scleroderma spectrum disorder…
Abstract Number: 685 • 2013 ACR/ARHP Annual Meeting
Lung Function and Survival In Systemic Sclerosis Associated Interstitial Lung Disease
Samar M. Shadly¹, Sindhu R. Johnson², Cathy Chau³ and Theodore K. Marras⁴, ¹Medicine, University Health Network Interstitial Lung Diseases Program, University Health Network and Mount Sinai Hospital, Toronto, ON, Canada, ²Medicine, Division of Rheumatology, Toronto Western Hospital, University Health Network Pulmonary Hypertension Programme, Toronto General Hospital, Mount Sinai Hospital and University of Toronto, Toronto, ON, Canada, ³Medicine, Toronto Scleroderma Program, Toronto Western Hospital, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, ⁴Medicine, University Health Network Interstitial Lung Diseases Program, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
Background/Purpose: We sought to assess for an association between baseline forced vital capacity (FVC) and diffusion capacity (DLCO) with mortality, and to identify threshold values…
Abstract Number: 686 • 2013 ACR/ARHP Annual Meeting
Blood Flow In The Hands Of a Predefined Homogeneous Systemic Sclerosis Population: The Presence Of Digital Ulcers and The Improvement With Bosentan
Jessica Meijs¹, Annemie J.M. Schuerwegh¹, Alexandre E. Voskuyl², Joanne P.J. Bloemsaat-Minekus³ and Madelon C. Vonk⁴, ¹Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ²Rheumatology, VU University Medical Center, Amsterdam, Netherlands, ³Actelion, Woerden, Netherlands, ⁴Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Background/Purpose: Digital ulcers (DU) are complications of systemic sclerosis (SSc) and arise as a result of ischaemia due to vasculopathy of the digital arteries (1).…
Abstract Number: 643 • 2013 ACR/ARHP Annual Meeting
Potential Immunopathological Roles Of The Novel Anti-Inflammatory Cytokine Interleukin-35 In Patients With Systemic Lupus Erythematous
Zhe Cai¹, Chun-Kwok Wong² and Lai Shan Tam³, ¹The Chinese University of Hong Kong, Hong Kong, Hong Kong, ²Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong, ³Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Background/Purpose: IL-35, a dimeric protein with two subunits, IL-12A (p35) and Epstein-Barr virus induced 3, is a novel IL-12 cytokine family regulatory T-cells (Treg)-specific immunosuppressive/anti-inflammatory…
Abstract Number: 644 • 2013 ACR/ARHP Annual Meeting
Expansion Of CD4⁺CXCR3⁺ T Cells In Patients With Systemic Lupus Erythematosus (SLE) Correlates With Subclinical Atherosclerosis
Karim Sacre¹, Brigitte Escoubet², Nicolas Charles³, Antoine Dossier⁴, Marie-Paule Chauveheid⁵ and Thomas Papo¹, ¹Internal Medicine, University Paris-7, INSERM U699, APHP, Bichat Hospital, Paris, France, ²Cardiology, University Paris-7, INSERM U872, APHP, Bichat Hospital, Paris, France, ³INSERM U699, Paris, France, ⁴Internal Medicine, University Paris-7, APHP, Bichat Hospital, Paris, France, ⁵Internal Medicine,, University Paris-7, APHP, Bichat Hospital, Paris, France
Background/Purpose: The mechanisms for accelerated atherosclerosis in SLE remain unclear. As atherosclerosis is itself immune-mediated, features of SLE-associated immunity might explain accelerated cardiovascular disease beside traditional…
Abstract Number: 645 • 2013 ACR/ARHP Annual Meeting
Transcript Profiling Of Blood and Kidney Biopsies From Chinese Patients With Lupus Nephritis Reveals Concordant Activation Of Type I IFN Signaling In The Blood and Kidney, Reduced B Cell Presence In The Blood, and Increased Macrophages In The Kidney
Zheng Liu¹, Chris, A. Morehouse¹, Xinfang Huang², Philip Brohawn¹, Nan Shen², Yihong Yao¹ and Brandon W. Higgs¹, ¹Translational Sciences, MedImmune, LLC, Gaithersburg, MD, ²Dept of Rheumatology, Shanghai Ren Ji Hospital, Shanghai, China
Background/Purpose: Up-regulated expression of type I interferon-regulated genes has consistently been observed within the peripheral blood in a large proportion of patients with active systemic…
Abstract Number: 646 • 2013 ACR/ARHP Annual Meeting
Expression Of Interferon-Inducible Gene (Lymphocyte Antigen 6 Complex Locus E) In Systemic Lupus Erythematosus Patients and Its Association With Disease Activity
Eman Omran¹, Tayseer M Khidre², Eman Alkady³, Eman Mosaad⁴ and Mona Hussein Abd Elsamea³, ¹Rheumatology and Clincal Immunology, Assiut University- Faulty of Medicne, Assiut, Egypt, ²Assiut University, Faculty of Medicine, Assiut, Egypt, ³Assiut University- Faculty of Medicine, Assiut, Egypt, ⁴AssiutUniversity- Faculty of Medicine, Assiut, Egypt
Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by immune dysregulation resulting in the production of antinuclear and other autoantibodies, generation of…
Abstract Number: 647 • 2013 ACR/ARHP Annual Meeting
Enhanced Expression of CCR Receptors in Healthy AA and SSc ILD Monocytes
Rebecca Lee¹, Charles Reese², Beth Perry³, Jonathan Heywood², Michael Bonner¹, Richard P. Visconti⁴, Richard M. Silver⁵, Stanley Hoffman³ and Elena Tourkina², ¹Division of Rheumatology, Medical University of South Carolina, Charleston, SC, ²Rheumatology, Medical University of SC, Charleston, SC, ³Rheumatology, Medical University of South Carolina, Charleston, SC, ⁴Cell Biology and Regenerative Medicine, Medical University of South Carolina, Charleston, SC, ⁵Div Rheumatology & Immunology, Medical University of South Carolina,Charleston,USA, Charleston, SC
Background/Purpose: Scleroderma-associated Interstitial Lung Disease (SSc ILD) is more prevalent and more severe in African Americans (AA) than in Caucasian (C) patients, but little is…
Abstract Number: 648 • 2013 ACR/ARHP Annual Meeting
A Possible Contribution of Inducible Costimulator to the Development of Skin Sclerosis and Interstitial Lung Disease in Systemic Sclerosis
Koichi Yanaba¹, Yoshihide Asano² and Shinichi Sato², ¹Dermatology, The University of Tokyo, Tokyo, Japan, ²Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
Background/Purpose: Systemic sclerosis (SSc) is a heterogeneous disorder characterized by excessive fibrosis and microvascular damage of the skin and various internal organs. Cutaneous mononuclear cell…
Abstract Number: 649 • 2013 ACR/ARHP Annual Meeting
Altered BMP Signalling In a TGFβ Dependent Murine Model Of Scleroderma May Contribute To Development Of Pulmonary Arterial Hypertension
Adrian J Gilbane¹, Emma C. Derrett-Smith², Sarah Trinder³, Andrew Pearce⁴, Christopher P. Denton¹ and Alan M. Holmes⁵, ¹Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, ²Centre for Rheumatology and Connective Tissue Diseases,, UCL Medical School Royal Free Campus, London, United Kingdom, ³Centre for Rheumatology and Connective Tissue Disease, UCL Medical School, London, United Kingdom, ⁴Respiratory Disease Area, Novartis, London, United Kingdom, ⁵Centre for Rheumatology and Connective Tissue Diseases, UCL, London, United Kingdom
Background/Purpose: Pulmonary arterial hypertension associated is an important complication of scleroderma (PAH-SSc) and has a poor prognosis compared to idiopathic (iPAH) or heritable (hPAH) forms…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].